MAGEA4 and esophageal cancer: Clinical trials are already underway for MAGEA4-directed adoptive T-cell therapies for patients with MAGEA4-enriched expression in esophageal cancer (39, 40) (https://clinicaltrials.gov/ct2/show/NCT04752358).